Immuno-intervention and preservation of beta-cell function in type 1 diabetes

This publication has 16 references indexed in Scilit:

• Treatment of new‐onset type 1 diabetes with peptide DiaPep277^® is safe and associated with preserved beta‐cell function: extension of a randomized, double‐blind, phase II trial
  Diabetes/Metabolism Research and Reviews, 2006
• Targeting Type 1 Diabetes Before and at the Clinical Onset of Disease
  Endocrine, Metabolic & Immune Disorders - Drug Targets, 2006
• Autoimmune Destruction of Pancreatic β Cells
  Clinical Journal of Sport Medicine, 2005
• Immunotherapy for the Prevention and Treatment of Type 1 Diabetes
  International Reviews of Immunology, 2005
• Neonatal oral administration of DiaPep277, combined with hydrolysed casein diet, protects against Type 1 diabetes in BB-DP rats. An experimental study
  Diabetologia, 2004
• Peptide therapy for Type I diabetes: the immunological homunculus and the rationale for vaccination
  Diabetologia, 2002
• Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus
  Immunology Letters, 2002
• Hsp60 Peptide Therapy of NOD Mouse Diabetes Induces a Th2 Cytokine Burst and Downregulates Autoimmunity to Various β-Cell Antigens
  Diabetes, 1997
• Detection of Autoantibodies to the Pancreatic Islet Heat Shock Protein 60 in Insulin-dependent Diabetes Mellitus
  Journal of Autoimmunity, 1996
• Increased Serum Levels of IgA Antibodies to hsp70 Protein in Patients with Diabetes Mellitus: Their Relationship with Vascular Complications
  Clinical Immunology and Immunopathology, 1996